Todd Zankel Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Todd Zankel.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Todd Zankel. Todd Zankel is Chief Scientific Officer in Raptor Pharmaceutical Corp ($RPTP).
Latest Insider Trading Transactions of Todd Zankel
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 28 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Option Exercise | A | 5.49 | 35,000 | 192,150 | 343,921 | |
Sep 05 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 5.00 | 842 | 4,210 | 651,866 | 652.7 K to 651.9 K (-0.13 %) |
Sep 04 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Option Exercise | M | 2.83 | 3,642 | 10,307 | 308,921 | |
Sep 04 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 5.00 | 3,858 | 19,290 | 652,708 | 656.6 K to 652.7 K (-0.59 %) |
Sep 04 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 5.00 | 3,642 | 18,210 | 656,566 | 660.2 K to 656.6 K (-0.55 %) |
Sep 04 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Buy | M | 2.83 | 3,642 | 10,307 | 660,208 | 656.6 K to 660.2 K (+0.55 %) |
Sep 04 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 5.00 | 2,648 | 13,240 | 656,566 | 659.2 K to 656.6 K (-0.40 %) |
Aug 31 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 5.01 | 10,136 | 50,781 | 659,214 | 669.4 K to 659.2 K (-1.51 %) |
Aug 29 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Option Exercise | M | 2.02 | 287 | 580 | 312,563 | |
Aug 29 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 5.00 | 287 | 1,435 | 669,350 | 669.6 K to 669.4 K (-0.04 %) |
Aug 29 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Buy | M | 2.02 | 287 | 580 | 669,637 | 669.4 K to 669.6 K (+0.04 %) |
May 02 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Option Exercise | M | 2.02 | 286 | 578 | 312,850 | |
May 02 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Option Exercise | M | 2.83 | 3,643 | 10,310 | 313,136 | |
May 02 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 5.85 | 17,484 | 102,194 | 669,350 | 686.8 K to 669.4 K (-2.55 %) |
May 02 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 5.82 | 3,929 | 22,867 | 686,834 | 690.8 K to 686.8 K (-0.57 %) |
May 02 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Buy | M | 2.02 | 286 | 578 | 690,763 | 690.5 K to 690.8 K (+0.04 %) |
May 02 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Buy | M | 2.83 | 3,643 | 10,310 | 690,477 | 686.8 K to 690.5 K (+0.53 %) |
Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Option Exercise | M | 2.02 | 287 | 580 | 316,779 | |
Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Option Exercise | M | 2.83 | 3,643 | 10,310 | 317,066 | |
Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.67 | 287 | 2,201 | 686,834 | 687.1 K to 686.8 K (-0.04 %) |
Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.84 | 100 | 784 | 687,121 | 687.2 K to 687.1 K (-0.01 %) |
Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.84 | 2,100 | 16,454 | 687,221 | 689.3 K to 687.2 K (-0.30 %) |
Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.83 | 615 | 4,815 | 689,321 | 689.9 K to 689.3 K (-0.09 %) |
Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.81 | 1,500 | 11,715 | 689,936 | 691.4 K to 689.9 K (-0.22 %) |
Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.81 | 200 | 1,561 | 691,436 | 691.6 K to 691.4 K (-0.03 %) |
Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.80 | 1,400 | 10,920 | 691,636 | 693 K to 691.6 K (-0.20 %) |
Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.76 | 200 | 1,552 | 693,036 | 693.2 K to 693 K (-0.03 %) |
Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.75 | 2,600 | 20,150 | 693,236 | 695.8 K to 693.2 K (-0.37 %) |
Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.74 | 700 | 5,418 | 695,836 | 696.5 K to 695.8 K (-0.10 %) |
Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.73 | 400 | 3,092 | 696,536 | 696.9 K to 696.5 K (-0.06 %) |
Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.72 | 1,300 | 10,036 | 696,936 | 698.2 K to 696.9 K (-0.19 %) |
Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.71 | 3,700 | 28,527 | 698,236 | 701.9 K to 698.2 K (-0.53 %) |
Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.70 | 300 | 2,309 | 701,936 | 702.2 K to 701.9 K (-0.04 %) |
Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.69 | 300 | 2,307 | 702,236 | 702.5 K to 702.2 K (-0.04 %) |
Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.68 | 600 | 4,608 | 702,536 | 703.1 K to 702.5 K (-0.09 %) |
Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.67 | 1,470 | 11,275 | 703,136 | 704.6 K to 703.1 K (-0.21 %) |
Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.67 | 1,443 | 11,068 | 704,606 | 706 K to 704.6 K (-0.20 %) |
Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.66 | 1,500 | 11,490 | 706,049 | 707.5 K to 706 K (-0.21 %) |
Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Sell | S | 7.65 | 700 | 5,355 | 707,549 | 708.2 K to 707.5 K (-0.10 %) |
Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Buy | M | 2.02 | 287 | 580 | 708,249 | 708 K to 708.2 K (+0.04 %) |
Feb 10 2012 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Buy | M | 2.83 | 3,643 | 10,310 | 707,962 | 704.3 K to 708 K (+0.52 %) |
Sep 26 2011 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Option Exercise | A | 5.13 | 87,345 | 448,080 | 320,709 | |
Sep 26 2011 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Option Exercise | A | 5.13 | 29,115 | 149,360 | 233,364 | |
Nov 23 2010 | RPTP | Raptor Pharmaceuti ... | Zankel Todd | Chief Scientific Of ... | Option Exercise | A | 3.54 | 87,345 | 309,201 | 165,526 |
Page: 1